drugset / Trial / NCT00545597
A Phase III Trial of Lorenzo's Oil in Adrenomyeloneuropathy
Phase 3
Terminated
240 enrolled
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Food and Drug Administration (FDA) · collab
RandomizedParallel-groupDouble-blindTreatment
Summary
Study of the use of Lorenzo's oil in adults with adrenomyeloneuropathy, the adult form of Lorenzo's oil.
Timeline
- Start
- 2005-03
- Primary completion
- 2007-10
- Completion
- 2007-10
Outcome
Outcome not reported
Stopped: “Upon recommendation of DSMB”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | glyceryl trioleate-glyceryl trierucate | Unknown | 10 % | Oral |